Together with single nucleotide polymorphism (SNP), copy number variations (CNV) are recognized to be the major component of human genetic diversity and used as a genetic marker in many disease association studies. Affymetrix Genome-wide SNP 5.0 is one of the commonly used SNP array platforms for SNP-GWAS as well as CNV analysis. However, there has been no report that validated the accuracy and reproducibility of CNVs identified by Affymetrix SNP array 5.0. In this study, we compared the characteristics of CNVs from the same set of genomic DNAs detected by three different array platforms; Affymetrix SNP array 5.0, Agilent 2X244K CNV array and NimbleGen 2.1M CNV array. In our analysis, Affymetrix SNP array 5.0 seems to detect CNVs in a reliable manner, which can be applied for association studies. However, for the purpose of defining CNVs in detail, Affymetrix Genome-wide SNP 5.0 might be relatively less ideal than NimbleGen 2.1M CNV array and Agilent 2X244K CNV array, which outperform Affymetrix array for defining the small-sized single copy variants. This result will help researchers to select a suitable array platform for CNV analysis.
Introduction
Recent progress of human genome mapping has facilitated the understanding of inter-individual differences in various phenotypes such as disease susceptibility and responsiveness to drugs (Estivill and Armengol, 2007) . Together with single nucleotide polymorphism (SNP), the large-scale genomic variations, which are named copy number variation (CNV), are recognized to be the major component of human genetic diversity (Freeman et al., 2006 ) and used as a genetic marker in many disease association studies.
Since the first discovery of CNV using BAC array platform, the microarray platforms for defining the global (Iafrate et al., 2004; Sebat et al., 2004) . Due to the improvement of technology and array resolution, the size of CNVs has been getting smaller and the number of CNVs detected per individual genome increasing. However, defining CNV is sensitive to choice of array platforms and detection algorithms. Indeed, the number and size of CNVs were diverse between the studies using different platform (Scherer et al., 2007) .
Among many whole-genome CNV analysis platforms, SNP arrays have been commonly used for CNV discovery due to its ubiquitous genome coverage and advantageous resolution. Also in Korea, SNP arrays have been frequently applied for CNV-disease association studies. The Korea Association Resource (KARE) consortium used the Affymetrix SNP array 5.0 genotyping data of 8,848 individuals provided by Korea National Health Institute (KNIH) for studying the associations between genetic variations and phenotypes. Using the same dataset, we previously reported the evolutionary and functional implications of the CNVs in Korean population (Yim et al., 2010) .
Despite the popularity of SNP arrays in studying CNVs, there are concerns regarding possibility of false discovery that can be caused by one-dye SNP arrays. There have been several reports comparing the array-CGH platforms for detecting CNVs (Baumbusch, 2008; Curtis and Lynch, 2010; Hester et al., 2009 ), but there has been no report that validated the accuracy and reproducibility of CNVs identified by Affymetrix SNP array 5.0. In this study, we compared the characteristics of CNVs from the same set of genomic DNAs detected by three different array platforms; Affymetrix SNP array 5.0, Agilent 2X244K CNV array and NimbleGen 2.1M CNV array. 
Methods

Study subject
Genomic DNA was isolated from two HapMap cell lines, GM10851 and GM15510 (Coriell, Camden, NJ, USA) with DNeasy Ⓡ Blood & Tissue Kit (Qiagen, Hilden, Germany).
Array hybridization and data processing
For CNV defining using Affymetrix Genome-wide SNP 5.0 platform, array hybridization and all the downstream data preprocessing procedures including allele correction, summarization and background correction were performed as described previously (Yim et al., 2010) .
For Agilent 2X244K CNV array, array hybridization and all the downstream data preprocessing were performed according to the manufacturer's instructions. In brief, 2ug of genomic DNA from NA10851 and NA15510 were digested with heat fragmentation method and the NA10851 cell line was labeled with Cy3-dUTP and NA15510 was labeled with Cy5-dUTP using Agilent Genomic DNA Enzymatic Labeling Kit (Agilent Technologies, Santa Clara, CA). Labeled DNAs were purified by Amicon Ultra-0.5 purification column (Millipore, Billerica, MA) and then pre-annealed with a blocking reagent (Agilent technologies) containing Cot-1 DNA (ConnectaGen, Seoul, Korea). Array hybridization was performed for 40 hours at 65 o C and 20 rpm. After hybridization, the arrays were washed and scanned with Agilent GA2565C scanner (Agilent technologies). Array images were analyzed with Feature Extraction software (Agilent Technologies) with the CGH-v4.95 protocol for normalization.
For NimbleGen 2.1M CNV array, array hybridization and all the downstream data preprocessing were performed according to the manufacturer's instructions. In brief, 2.5 ug of genomic DNA from the NA10851 cell line was labeled with Cy3-labeled NimbleGen validated Random 9mer (TriLink BioThchknologies, San Diego, CA) and NA15510 was labeled with Cy5-labeled NimbleGen validated Random 9mer (TriLink BioTechnologies) using Klenow Fragment (NEB, Ipswich, MA). Labeled reference and test DNA were combined, denatured and pre-annealed with 2X Hybridization Buffer (Roche NombleGen, Madison, WI). The mixed DNA was hybridized onto the arrays for 72 hours in a MAUI hybridization machine (BioMicro, Utah) at 42 o C. After hybridization, the arrays were washed and scanned with GenePix 4000B scanner (Molecular Devices, Sunnyvale, CA). Array images were analyzed with NimbleScan v2.6 (Roche NombleGen).
Defining CNVs
All the data sets from the three different platforms were analyzed using the rank segmentation method of NEXUS software (BioDiscovery) under the same threshold. NEXUS is the algorithm that recursively divides chromosomes into segments of common intensity distribution functions like the circular binary segmentation (CBS).
Result and Discussion
Based on the rank segmentation algorithm, we defined the CNVs between NA10851 and NA15510 using the three different array platforms. Details of the identified CNVs are summarized in Table 1 . Although the same DNA was analyzed by the same detection algorithm, the number of CNVs varied from 102 to 608 depending on the types of the array used. The smallest number of CNVs were identified by Affymetrix SNP 5.0, while Agilent 2X244K and NimbleGen 2.1M arrays defined 3 to 6 times more CNVs. Gain/loss ratio of the CNVs identified by Affymetrix SNP 5.0, Agilent 2X244K and NimbleGen 2.1M arrays were 0.89 (48/54), 0.99 (188/189), and 3.57 (475/133), respectively. In spite of the large difference in the number of identified CNVs among the platforms, the total CNV coverage of the genome was all similar in three the platforms, ranging from 6.7% to 9.9% of the genome. The median size of the CNVs was largest for Affymetrix SNP 5.0 and smallest for Agilent 2X244K array.
Of the 102 CNVs identified by Affymetrix 5.0, 76 CNVs (75%) were consistently detected by the other two platforms. Among them, 71 (93%) CNVs overlap the CNV in DGV. Fig. 1A illustrates the example of a CNV identified by all three platforms. This 35 kb sized copy number gain on 13q is located within the previously reported CNV in DGV and its boundaries were almost same boundaries regardless of the platforms. Fig. 1B illustrates the example of a CNV identified by Agilent 2X244K and NimbleGen 2.1M arrays but not by Affymetrix 5.0 array. This 9 kb sized copy number loss on 17p also overlaps the CNV in DGV. Its boundaries were defined almost identically by Agilent 2X244K and NimbleGen 2.1M arrays. This data reflects relatively low resolution of Affymetrix 5.0 array, which makes the platform less efficient for detecting small sized CNVs.
Due to the widespread availability, SNP array has been frequently used for genome-wide CNV discovery and CNV-disease association studies. Affymetrix Genome-wide SNP 5.0 is one of the commonly used SNP array platforms for SNP-GWAS as well as CNV analysis in Korea. In our analysis, Affymetrix SNP array 5.0 seems to detect CNVs in a reliable manner, which can be applied for association studies. However, for the purpose of defining CNVs in detail, Affymetrix Genome-wide SNP 5.0 might be relatively less ideal than NimbleGen 2.1M CNV array and Agilent 2X244K CNV array, which outperform Affymetrix array for defining the small-sized single copy variants.
